Federated Hermes, Inc. Kal Vista Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$17.11 - $24.49 $667 - $955	-39 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$14.69 - $42.57 $572 - $1,660	39 New	39 $1,000
Q2 2020 Aug 13, 2020	SELL	$6.75 - $12.89 $1,795 - $3,428	-266 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$5.8 - $18.56 $1,542 - $4,936	266 New	266 $2,000
Q2 2019 Aug 14, 2019	SELL	$18.44 - $30.89 $9,054 - $15,166	-491 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$16.51 - $31.1 $3,384 - $6,375	205 Added 71.68%	491 $14,000
Q4 2018 Feb 13, 2019	BUY	$16.21 - $24.06 $2,236 - $3,320	138 Added 93.24%	286 $5,000
Q3 2018 Nov 13, 2018	BUY	$8.0 - $22.11 $1,184 - $3,272	148 New	148 $3,000
Q2 2018 Aug 10, 2018	SELL	$7.79 - $9.84 $3,918 - $4,949	-503 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$9.22 - $12.35 $4,637 - $6,212	503 New	503 $5,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $248M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.